The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient careShirin Karimi, Gelareh Zadeh, Farshad Nassiri et al.|Clinical Epigenetics|2019Cited by 89
Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classificationJeffrey Zuccato, Gelareh Zadeh, Farshad Nassiri et al.|Neuro-Oncology|2022Cited by 69
DNA methylation-based prognostic subtypes of chordoma tumors in tissue and plasmaJeffrey Zuccato, Gelareh Zadeh, Homa Adle‐Biassette et al.|Neuro-Oncology|2021Cited by 62
Liquid Biomarkers for Improved Diagnosis and Classification of CNS TumorsSevera Bunda, Gelareh Zadeh, Mathew Voisin et al.|International Journal of Molecular Sciences|2021Cited by 38
Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignanciesNicholas Mikolajewicz, Alireza Mansouri, Vladmir Ignatchenko et al.|Neuro-Oncology Advances|2022Cited by 23